Biomarkers in clinical epidemiology studies

Carmine Zoccali,Giovanni Tripepi,Vianda Stel,Eduard L Fu,Francesca Mallamaci,Friedo Dekker,Kitty J Jager

DOI: https://doi.org/10.1093/ckj/sfae130

2024-04-25

Clinical Kidney Journal

Abstract:Abstract This paper discusses the use of biomarkers in clinical practice and biomedical research. Biomarkers are measurable characteristics that can be used to indicate the presence or absence of a disease or to track the progression of a disease. They can also be used to predict how a patient will respond to a particular treatment. Biomarkers have enriched clinical practice and disease prognosis by providing measurable characteristics that indicate biological processes. They offer valuable insights into disease susceptibility, progression, and treatment response, aiding drug development and personalised medicine. However, developing and implementing biomarkers come with challenges that must be addressed. Rigorous testing, standardisation of assays, and consideration of ethical factors are crucial in ensuring the reliability and validity of biomarkers. Reliability is vital in biomarker research. It ensures accurate measurements by preventing biases and facilitating robust correlations with outcomes. Conversely, validation examines which and how much biomarkers correspond to theoretical constructs and external criteria, establishing their predictive value. Multiple biomarkers are sometimes necessary to represent the complex relationship between exposure and disease outcomes accurately. Susceptibility factors are pivotal in disease states' complex interaction among genetic and environmental factors. Gaining a comprehensive understanding of these factors is essential for effectively interpreting biomarker data and maximizing their clinical usefulness. Using well-validated biomarkers can improve diagnoses, more effective treatment evaluations, and enhanced disease prediction. This, in turn, will contribute to better patient outcomes and drive progress in medicine.

urology & nephrology

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the applications and challenges of biomarkers in clinical practice and biomedical research. Specifically, the paper explores the following aspects:

1. **Definition and Classification of Biomarkers**:
- Biomarkers are defined as measurable characteristics that are used to indicate normal biological processes, pathological processes, or responses to exposures or interventions (including therapeutic interventions).
- Biomarkers can be divided into different categories such as genomics, proteomics, metabolomics, etc., and can also be classified into diagnostic, prognostic, and predictive biomarkers according to their clinical uses.

2. **The Role of Biomarkers in Disease Diagnosis, Prognosis, and Treatment**:
- Biomarkers play an important role in the diagnosis, prognosis, and treatment of various diseases such as cancer, cardiovascular diseases, and neurodegenerative diseases.
- They can be used to identify patients who are most likely to respond to specific therapies, monitor the effectiveness and safety of treatment, thus supporting the development of precision medicine.

3. **Challenges in the Development and Implementation of Biomarkers**:
- The development and implementation of effective biomarkers face many challenges, including rigorous testing, standardized detection methods, and consideration of ethical factors.
- Ensuring the reliability and validity of biomarkers is crucial, which requires strict validation in large and diverse patient populations and the establishment of standardized detection methods.

4. **Reliability and Validation of Biomarkers**:
- Reliability ensures the accuracy of measurement, avoids bias, and promotes a robust correlation with results.
- Validation assesses the correspondence of biomarkers with theoretical constructs and external standards and determines their predictive value.

5. **Application of Multiple Biomarkers**:
- Sometimes multiple biomarkers are required to accurately represent the complex relationship between exposure and disease outcomes.
- For example, in the study of chronic kidney disease (CKD), by measuring multiple inflammation - related biomarkers, a more comprehensive understanding of the relationship between inflammation and CKD progression can be obtained.

6. **The Influence of Susceptibility Factors**:
- Susceptibility factors play an important role in disease states, and these factors include the interaction between genetic and environmental factors.
- A comprehensive understanding of these factors is essential for effectively interpreting biomarker data and maximizing their clinical utility.

In conclusion, this paper aims to explore the applications of biomarkers in clinical epidemiological research and the challenges they face, emphasizing the importance of biomarkers in disease management, treatment optimization, and biomedical research.